Publications:  Miss Hothri Moka

Kinstrie R, Horne GA, Morrison H, Irvine D, Munje C, Castañeda EG, Moka HA, Dunn K et al.(2020). CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy. Leukemia vol. 34, (6) 1613-1625.

Kinstrie R, Horne GA, Morrison H, Irvine D, Munje C, Castañeda EG, Moka HA, Dunn K et al.(2020). Correction: CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy (Leukemia, (2020), 10.1038/s41375-019-0684-5). Leukemia

O'Connor C, Yalla K, Salomé M, Moka HA, Castañeda EG, Eyers PA, Keeshan K(2018). Trib2 expression in granulocyte-monocyte progenitors drives a highly drug resistant acute myeloid leukaemia linked to elevated Bcl2. Oncotarget vol. 9, (19) 14977-14992.

Irvine DA, Zhang B, Kinstrie R, Tarafdar A, Morrison H, Campbell VL, Moka HA, Ho Y et al.(2016). Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia. Scientific Reports vol. 6,

Kinstrie R, Horne GA, Morrison H, Moka HA, Cassels J, Dunn K, Herzyk P, Irvine DA et al. (2015). CD93 Is a Novel Biomarker of Leukemia Stem Cells in Chronic Myeloid Leukemia. BLOOD. vol. 126,

Tarafdar A, Khan AF, Cosimo E, Moka HA, Dunn K, Michie AM (2015). Subversion of Pkca and Pkcbii Upregulation Play an Essential Role in Chronic Lymphocytic Leukaemia Development, Inducing Constitutive B Cell Receptor-Mediated Signals. BLOOD. vol. 126,